Table of Contents
Why Did Every State Join Trump’s Drug Pricing Push?
President Donald J. Trump announced that Most Favored Nation pricing now applies to Medicaid programs in all 50 states, the District of Columbia, and Puerto Rico, projecting tens of billions of dollars in savings over the next decade. He called the expansion historic action that ends Americans paying the world’s highest drug prices, building on deals that delivered the sharpest annual drop in prescription costs in more than 60 years.
How Most Favored Nation Pricing Delivers National Savings
Twenty-six manufacturers covering about 90 percent of the branded U.S. market agreed to align selected American prices with the lowest paid by comparable developed nations. The White House projects nearly $65 billion in Medicaid drug savings over ten years, including roughly $27.6 billion for states and $36.6 billion for the federal government. Official data confirm the largest annual decline in prescription prices since 1963, with prices falling every month of 2026. Broader agreements are projected to save Americans more than $600 billion.
How Officials Say States Can Redirect Savings
In an Oval Office event with governors from Arkansas, Mississippi, and South Dakota, Trump said the program launches with every state, red and blue, and that jurisdictions can use extra billions for other healthcare improvements. Vice President JD Vance praised the results, noting Democrats’ unfulfilled promises while states can now redirect Medicaid savings to better care. The same companies committed about $170 billion to U.S. manufacturing and research and are stocking a Strategic Active Pharmaceutical Ingredients Reserve.
What Patients Already Save on TrumpRx
TrumpRx has delivered more than $700 million in savings and now covers more than 1,000 branded and generic medicines. GLP-1 drugs that once cost over $1,000 a month start as low as $149; eligible Medicare seniors pay $50 a month, with more than 500,000 seniors already saving $216 million. Patients have already seen hundreds of millions in savings via the TrumpRx platform. Critics point out that exact figures depend on confidential terms of the GENEROUS model, yet the published decade estimates and early platform results establish a clear downward path.
What Nationwide Access Means for Taxpayers
Statutory rebates already apply, so incremental savings vary by product. Even so, expanding Medicaid Most Favored Nation access nationwide gives every jurisdiction the same pricing tool. Future launches from participating firms are slated to enter U.S. markets at internationally aligned levels. The completed framework means Medicaid programs everywhere can buy participating products at those prices, taxpayers keep more of every appropriated dollar, and families see the first sustained drop in prescription costs in two generations.
Read More: https://morsereport.com/a/news/us-poverty-rate-falls-to-102-as-income-hits-87460
Republic Trucker Hat - Navy / White
$45.00
SHIPPING FOREWORD: Because all Morse Report products are 100% sourced and manufactured inside of the United States of America at the highest standard of excellence, shipping fulfillment can take anywhere from 5 - 14 days, depending on conditions. THANK YOU!… read more
FAQs
Why Did Every State Join Trump’s Drug Pricing Push?
President Donald J. Trump announced that Most Favored Nation pricing now applies to Medicaid programs in all 50 states, the District of Columbia, and Puerto Rico, projecting tens of billions of dollars in savings over the next decade. He called the expansion historic action that ends Americans paying the world’s highest drug prices, building on deals that delivered the sharpest annual drop in prescription costs in more than 60 years.
